Details for 2020729201
Up to date per 11.05.2026
Actions
Details for 2020729201
Granted/Registered
European Patent
30.03.2022 A
24.12.2025 B1
23.05.2019
US
201962851986 P
C07D 239/47 20060101AFI20201127BHEP
Owner
Novartis AGLichtstrasse 35 4056 BaselCH
Representative
No representatives present
Inventor
ANGST, DanielaNovartis Pharma AG, Novartis Institutes for Biomed. Research, Postfach 4002 BaselCH
KORDIKOWSKI, AndreasNovartis Pharma AG, Postfach 4002 BaselCH
Information about Fees